Clinical Trials on Carcinoma, Non-Small Cell in South Africa
Total 1640 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Non Small Cell Lung CancerDenmark, United States, Argentina, Australia, Austria, Belgium, Brazil, Finland, France, Germany, Israel, Italy, Korea, Republic of, Malaysia, Poland, Russian Federation, Spain, Switzerland, Taiwan, Thailand
-
GlaxoSmithKlineActive, not recruitingLung Cancer, Non-Small CellArgentina, France, Spain, Italy, Belgium, Korea, Republic of, United States, Mexico, Hungary, Sweden, Turkey, Ireland, Greece, Russian Federation, Germany, Netherlands, Bulgaria, Romania, Brazil, United Kingdom, Poland, Australia, C... and more
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupTerminatedRecurrent Non-Small Cell Lung Carcinoma | Metastatic Malignant Neoplasm in the Brain | Stage IV Non-Small Cell Lung Cancer AJCC v7United States, Canada
-
Ariad PharmaceuticalsCompletedCarcinoma | Lung Cancer | Non-small Cell Lung Cancer | Advanced MalignanciesUnited States, Canada, Germany, Spain, Taiwan, Korea, Republic of, Switzerland, Hong Kong, Singapore, Italy, Sweden, United Kingdom, France, Netherlands, Denmark, Australia, Norway, Austria, Luxembourg
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group B; North...CompletedLung Cancer | Radiation ToxicityUnited States, Canada
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerBelgium, Italy, Spain, United States, Poland, India, Taiwan, Thailand, Vietnam, Canada, France, Germany, Korea, Republic of, Brazil, Hungary, Japan, Mexico, Peru, Philippines, Russian Federation, China, Austria, Chile, Netherlands, Bulg... and more
-
Astellas Pharma IncOSI PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited States
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, Australia, Korea, Republic of, Canada, Poland, Spain, Vietnam, Germany, Brazil, Italy, Japan, Taiwan, Thailand, United States, United Kingdom, Portugal, Turkey, France, Peru, Colombia, Russian Federation, Ukraine
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminated
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Belgium, Hong Kong, Italy, Slovenia, Australia, Canada, Bulgaria, Germany, France, Georgia, Singapore, Spain, Bosnia and Herzegovina, Switzerland, Turkey, Japan, United Kingdom, Netherlands
-
NCIC Clinical Trials GroupPfizerCompletedLung CancerTaiwan, Canada, Australia, Italy, New Zealand, United States, Thailand, Korea, Republic of, Brazil, Argentina, Philippines, Peru
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerUnited States, Spain, Italy, Taiwan, Belgium, China, Hong Kong, Japan, Germany, Canada, Israel, Russian Federation, United Kingdom, France, Korea, Republic of, Poland, Netherlands, Ukraine, Romania, Australia, Hungary, Portugal
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingNon-Small Cell Lung CancerChina, Spain, Canada, Israel, Italy, Japan, Korea, Republic of, Taiwan, Australia, Poland, Brazil, Turkey, Belgium, Singapore, Czechia, Romania, Germany, Russian Federation, Greece, Netherlands, Argentina, France, Hong Kong, Mexico, Ukr... and more
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
Merck Sharp & Dohme LLCActive, not recruitingNon-Small Cell Lung CancerPoland, United States, Brazil, France, Guatemala, Hungary, Japan, Korea, Republic of, Peru, Romania, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine
-
SanofiCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Terminated
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States, France, Hungary, Australia, Brazil, Canada, Spain, Germany, United Kingdom, Chile, Israel, Italy, Netherlands, Argentina, Ukraine, Russian Federation
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingNon-Small Cell Lung CancerUnited States, Italy, Poland, Spain, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Japan, Korea, Republic of, Lebanon, Mexico, Netherlands and more
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Australia, Canada, Netherlands, Finland, Taiwan, Czechia, Estonia, Spain, Argentina, Belgium, France, Sweden, Germany, Israel, Italy, Korea, Republic of, Singapore, Ukraine, United Kingdom, Austria, Ireland, Thailand, C... and more
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest... and other collaboratorsCompletedLung CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingLung CancerUnited States, Canada, Australia
-
Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung NeoplasmsAustralia, Singapore, Netherlands
-
National Cancer Institute (NCI)Active, not recruitingLung Adenocarcinoma | Lung Large Cell Carcinoma | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Minimally Invasive Lung Adenocarcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7 | Lung Squamous Cell Carcinoma | Lung Adenocarcinoma, Mixed SubtypeUnited States
-
National Cancer Institute (NCI)CompletedExtensive Stage Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerItaly, Belgium, Israel, Sweden, China, Hong Kong, Australia, Colombia, Romania, Germany, Ireland, Mexico, Korea, Republic of, Taiwan, Turkey, Russian Federation, Czech Republic, Hungary, Netherlands, New Zealand, Peru, Finland, Austria and more
-
Pharmassist LtdUniversity of AthensActive, not recruitingMelanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaGreece
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLung CancerUnited States, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung Cancer | Lung CancerItaly, Korea, Republic of, Turkey, Canada, Spain, Australia, Mexico, Taiwan, France, Germany, Switzerland, Greece, Japan, Austria, United States, Brazil, Czechia
-
Cancer Trials IrelandTerminatedColorectal Cancer | Non-Small Cell Lung CancerIreland
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Lung Small Cell CarcinomaUnited States, Canada, Korea, Republic of, Mexico
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerUnited States, Korea, Republic of, Canada, Taiwan, Australia, France, Hong Kong, Italy, Portugal, Spain, United Kingdom, Brazil, Poland, Guatemala, Singapore, Thailand, Serbia, Ukraine, Bosnia and Herzegovina, China, Costa Rica, E... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerUnited States, Germany, Belgium, Italy, France, Canada, Hungary, Poland, Switzerland, Spain
-
Eli Lilly and CompanyCompletedColorectal Cancer | Metastatic Melanoma | Advanced Cancer | Metastatic Non-small Cell Lung CancerUnited States, Japan, Australia, France
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States